Evotec to Present at the Morgan Stanley 18th Annual Global Healthcare Conference

Evotec SE (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that Cord Dohrmann, Chief Executive Officer, will present at the Morgan Stanley 18th Annual Global Healthcare Conference on Tuesday, September 13, 2022, at 7.45 am ET.

The live webcast of the presentation will be available via the following link:

https://www.morganstanley.com/ideas/ms-global-healthcare-conference-webcast-registration

A replay of the webcast will be available one hour after the live presentation and will be accessible for 90 days.

About Evotec SE

Evotec is a leading drug discovery alliance and development partnership company focused on rapidly translating scientific innovations into best-in-class drugs to address unmet medical needs.

The Company’s unique business model and highly integrated, end-to-end drug discovery platform allows it to target orphan diseases and underserved therapeutic areas, where there is a high unmet medical need and a lack of available therapies.

Evotec has established multiple long-term discovery alliances and development partnerships with leading pharmaceutical companies, biotech companies, academic institutions, patients and disease foundations, and venture capitalists for a wide range of therapeutic indications.